684 related articles for article (PubMed ID: 32449791)
1. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
Lara B; Carnes A; Dakterzada F; Benitez I; Piñol-Ripoll G
Eur J Neurol; 2020 Sep; 27(9):1744-1747. PubMed ID: 32449791
[TBL] [Abstract][Full Text] [Related]
2. [Neuropsychiatric symptoms in people living with dementia related to COVID-19 pandemic lockdown. Exploratory systematic review].
Sánchez-García M; Rodríguez-Del Rey T; Pérez-Sáez E; Gay-Puente FJ
Rev Neurol; 2022 Feb; 74(3):83-92. PubMed ID: 35084733
[TBL] [Abstract][Full Text] [Related]
3. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.
Boutoleau-Bretonnière C; Pouclet-Courtemanche H; Gillet A; Bernard A; Deruet AL; Gouraud I; Mazoue A; Lamy E; Rocher L; Kapogiannis D; El Haj M
J Alzheimers Dis; 2020; 76(1):41-47. PubMed ID: 32568211
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
[TBL] [Abstract][Full Text] [Related]
7. The impact of COVID-19 pandemic on elderly with neurocognitive disorders.
Basta M; Skourti E
Psychiatriki; 2023 Oct; 34(3):177-180. PubMed ID: 37449850
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima, Peru.
Custodio N; Malaga M; Montesinos R; Chambergo D; Baca F; Castro S; Carbajal JC; Herrera E; Lira D; Diaz MM; Lanata S
Curr Alzheimer Res; 2023; 20(2):80-88. PubMed ID: 37073648
[TBL] [Abstract][Full Text] [Related]
9. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
11. Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.
Salem H; Suchting R; Gonzales MM; Seshadri S; Teixeira AL
J Alzheimers Dis; 2023; 92(1):129-139. PubMed ID: 36710674
[TBL] [Abstract][Full Text] [Related]
12. The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis.
Soysal P; Smith L; Trott M; Alexopoulos P; Barbagallo M; Tan SG; Koyanagi A; Shenkin S; Veronese N;
Psychogeriatrics; 2022 May; 22(3):402-412. PubMed ID: 35128762
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
M FM; Molano A; Castro J; Zarranz JJ
Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
[TBL] [Abstract][Full Text] [Related]
16. Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
Aguilar-Barberà M; Soler-Girabau P; Tabuenca-Martín AI; Prieto-Del Val L
J Alzheimers Dis; 2023; 93(2):621-631. PubMed ID: 37066911
[TBL] [Abstract][Full Text] [Related]
17. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.
Canevelli M; Adali N; Cantet C; Andrieu S; Bruno G; Cesari M; Vellas B;
J Neurol; 2013 Jul; 260(7):1859-65. PubMed ID: 23504051
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric Symptoms in Patients With Alzheimer's Disease During SARS-COV-2 Pandemic in Peru.
Custodio N; Castro-Suárez S; Montesinos R; Failoc-Rojas VE; Cruz Del Castillo R; Herrera-Perez E
Am J Alzheimers Dis Other Demen; 2021; 36():15333175211039089. PubMed ID: 34416114
[TBL] [Abstract][Full Text] [Related]
19. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease.
Tanaka H; Hashimoto M; Fukuhara R; Ishikawa T; Yatabe Y; Kaneda K; Yuuki S; Honda K; Matsuzaki S; Tsuyuguchi A; Hatada Y; Ikeda M
Psychogeriatrics; 2015 Dec; 15(4):242-7. PubMed ID: 25737233
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
